Pharmaceutical company Zentiva posts 13% growth in profit in first half
Zentiva had a total revenues of EUR 32.4 million (RON 135.6 million) in the first six months, with 3 percent higher than the amount reported in the same period last year. The company's total expenses reached EUR 23.6 million (RON 98.8 million), down one percent compared to 2010.
Zentiva is part of the Sanofi – Aventis group. The company runs production units in Romania, Turkey, the Czech Republic and Slovakia.
Irina Popescu, irina.popescu@romania-insider.com
(photo source: Sxc.hu)